Encore Medical (EMI) files for proposed IPO

Encore Medical (NYSE: EMI) has filed for a proposed IPO.

The company describes itself as: "We develop, manufacture, and market septal occlusion products, which are small, implantable devices delivered through a catheter inserted into a major blood vessel to permanently repair certain cardiac defects. Our devices include patented technology that has been in use extensively outside of the U.S. Procedures are performed in a cardiac catheterization lab and reduce the need for open heart surgery or a lifetime of drug therapy, which are currently the primary alternative methods for treating these defects. We have developed devices capable of providing effective, nonsurgical methods of correcting a variety of cardiac defects in both adults and children."

OAK RIDGE FINANCIAL and Dawson James Securities will serve as underwriters.

You May Also Be Interested In

• Shein targets $26-27 billion valuation in Hong Kong IPO - report
• Guggenheim Reiterates Buy Rating on EyePoint Inc. (EYPT)
• BofA sees dollar weakness continuing with New Zealand dollar gains